Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer

After primary treatment for prostate cancer with either radical prostatectomy or radiotherapy, a significant proportion of patients are at risk of developing metastases. In recent years, a deeper understanding of the underlying biology together with improved imaging techniques and the advent of new...

Descripción completa

Detalles Bibliográficos
Autores principales: Marvaso, Giulia, Volpe, Stefania, Pepa, Matteo, Zaffaroni, Mattia, Corrao, Giulia, Augugliaro, Matteo, Nolè, Franco, De Cobelli, Ottavio, Jereczek-Fossa, Barbara Alicja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747627/
https://www.ncbi.nlm.nih.gov/pubmed/35023972
http://dx.doi.org/10.2147/CMAR.S321136
_version_ 1784630873766756352
author Marvaso, Giulia
Volpe, Stefania
Pepa, Matteo
Zaffaroni, Mattia
Corrao, Giulia
Augugliaro, Matteo
Nolè, Franco
De Cobelli, Ottavio
Jereczek-Fossa, Barbara Alicja
author_facet Marvaso, Giulia
Volpe, Stefania
Pepa, Matteo
Zaffaroni, Mattia
Corrao, Giulia
Augugliaro, Matteo
Nolè, Franco
De Cobelli, Ottavio
Jereczek-Fossa, Barbara Alicja
author_sort Marvaso, Giulia
collection PubMed
description After primary treatment for prostate cancer with either radical prostatectomy or radiotherapy, a significant proportion of patients are at risk of developing metastases. In recent years, a deeper understanding of the underlying biology together with improved imaging techniques and the advent of new therapeutic options including metastases-directed therapies and new drugs have revolutionized the management of low-burden metastatic disease, also known as oligometastatic state. The purpose of this narrative review is to report the recent developments in the management of hormone-sensitive oligometastatic prostate cancer patients.
format Online
Article
Text
id pubmed-8747627
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-87476272022-01-11 Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer Marvaso, Giulia Volpe, Stefania Pepa, Matteo Zaffaroni, Mattia Corrao, Giulia Augugliaro, Matteo Nolè, Franco De Cobelli, Ottavio Jereczek-Fossa, Barbara Alicja Cancer Manag Res Review After primary treatment for prostate cancer with either radical prostatectomy or radiotherapy, a significant proportion of patients are at risk of developing metastases. In recent years, a deeper understanding of the underlying biology together with improved imaging techniques and the advent of new therapeutic options including metastases-directed therapies and new drugs have revolutionized the management of low-burden metastatic disease, also known as oligometastatic state. The purpose of this narrative review is to report the recent developments in the management of hormone-sensitive oligometastatic prostate cancer patients. Dove 2022-01-06 /pmc/articles/PMC8747627/ /pubmed/35023972 http://dx.doi.org/10.2147/CMAR.S321136 Text en © 2022 Marvaso et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Marvaso, Giulia
Volpe, Stefania
Pepa, Matteo
Zaffaroni, Mattia
Corrao, Giulia
Augugliaro, Matteo
Nolè, Franco
De Cobelli, Ottavio
Jereczek-Fossa, Barbara Alicja
Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer
title Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer
title_full Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer
title_fullStr Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer
title_full_unstemmed Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer
title_short Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer
title_sort recent advances in the management of hormone-sensitive oligometastatic prostate cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747627/
https://www.ncbi.nlm.nih.gov/pubmed/35023972
http://dx.doi.org/10.2147/CMAR.S321136
work_keys_str_mv AT marvasogiulia recentadvancesinthemanagementofhormonesensitiveoligometastaticprostatecancer
AT volpestefania recentadvancesinthemanagementofhormonesensitiveoligometastaticprostatecancer
AT pepamatteo recentadvancesinthemanagementofhormonesensitiveoligometastaticprostatecancer
AT zaffaronimattia recentadvancesinthemanagementofhormonesensitiveoligometastaticprostatecancer
AT corraogiulia recentadvancesinthemanagementofhormonesensitiveoligometastaticprostatecancer
AT augugliaromatteo recentadvancesinthemanagementofhormonesensitiveoligometastaticprostatecancer
AT nolefranco recentadvancesinthemanagementofhormonesensitiveoligometastaticprostatecancer
AT decobelliottavio recentadvancesinthemanagementofhormonesensitiveoligometastaticprostatecancer
AT jereczekfossabarbaraalicja recentadvancesinthemanagementofhormonesensitiveoligometastaticprostatecancer

Ejemplares similares